Current guidelines recommend anticoagulant therapy with vitamin K antagonists, such as warfarin, for just 3-6 months after bioprosthetic valve replacement, even for patients in sinus rhythm.

MEDLINE 16. David TE, Ivanov J, Armstrong S, Feindel CM, Cohen G: Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg 2001; 121: 268–77.

Izumi noted that NOACs have been increasingly used at discharge for patients following bioprosthetic valve replacement “despite this being an off-label use for patients with sinus rhythm.” But ...

Current guidelines recommend anticoagulant therapy for 3-6 months following bioprosthetic valve replacement, including in patients with sinus rhythm, but only warfarin is recommended and approved ...

The randomized, multi-center trial included approximately 400 adults in Japan who had bioprosthetic heart valve replacement surgery at the aortic and/or mitral position. Researchers randomized the ...

The randomized, multi-center trial included approximately 400 adults in Japan who had bioprosthetic heart valve replacement surgery at the aortic and/or mitral position. Researchers randomized the ...

Repair procedures based on the use of bioprosthetic plugs were developed to assist fistula healing and improve continence by preventing surgical trauma to the sphincter muscle. Ellis and ...

A farmer and teacher by profession, he exemplified the spirit of resilience, undergoing an extraordinary medical journey to ...

Patients who receive a heart valve replacement are well-known to be ... Patients who receive a bioprosthetic (made with human or animal tissue) heart valve typically need anticoagulants for ...

The randomized, multi-center trial included approximately 400 adults in Japan who had bioprosthetic heart valve replacement surgery at the aortic and/or mitral position. Researchers randomized the ...